Pharmacogenetics and ethical considerations: why care?-Reference-Cited by-同舟云学术

Pharmacogenetics and ethical considerations: why care?

Published:2006-10-10 Issue:5 Volume:7 Page:293-296
ISSN:1470-269X
Container-title:The Pharmacogenomics Journal
language:en
Short-container-title:Pharmacogenomics J

Author:

Marx-Stölting L

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,Genetics,Molecular Medicine

Link

http://www.nature.com/articles/6500425.pdf

Reference22 articles.

1. Nuffield Council on Bioethics. Pharmacogenetics: Ethical Issues. Nuffield Council on Bioethics: London, 2003.

2. Rippe KP, Bachmann A, Faisst K, Oggier W, Pauli-Magnus C, Probst-Hensch N et al. (TA SWISS): Pharmakogenetik und Pharmakogenomik. TA 48/2004. Bern 2004.

3. European Commission. Ethical, Legal and Social Aspects of Genetic Testing: Research, Development and Clinical Applications. Report of the STRATA Expert Group: Brussels, 2004.

4. Mahlknecht U, Voelter-Mahlknecht S . Pharmacogenomics: questions and concerns. Curr Med Res Opin 2005; 21: 1041–1047.

5. van Delden J, Bolt I, Kalis A, Derijks J, Leufkens H . Tialor-made pharmacotherapy: future developments and ethical challenges in the field of pharmacogenomics. Bioethics 2004; 18: 303–321.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenetic testing utility in psychiatry: A case report of serotonin syndrome;Psychiatry Research Case Reports;2023-06

2. Clinical pharmacology applications in clinical drug development and clinical care: A focus on Saudi Arabia;Saudi Pharmaceutical Journal;2020-10

3. Knowledge, attitudes and education of pharmacists regarding pharmacogenetic testing;Personalized Medicine;2012-01

4. Challenges and Pitfalls in the Introduction of Pharmacogenetics for Cancer;Annals of the Academy of Medicine, Singapore;2011-08-15

5. Attitudes of Health Care Professionals Toward Pharmacogenetic Testing;Molecular Diagnosis & Therapy;2011-04